PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 20, 2026Journal of Neurology3 citations

Early-phase fluid diagnostic biomarkers in acute ischemic stroke: a hybrid umbrella review

View Full Paper
ABAlessandro BombaciFPFederico Emanuele PozziSMSalvatore Mazzeo

Key Points

  • This research aims to evaluate the effectiveness of fluid biomarkers in diagnosing acute ischemic stroke.
  • Conducted a hybrid umbrella review of systematic reviews and meta-analyses
  • Performed random effects meta-analysis of standardized mean differences
  • Included 27 publications covering biochemistry, metabolomic, and transcriptomic studies
  • Found significant biomarkers such as NSE, IMA, and d-dimer with effect sizes across time points
  • Revealed early metabolite accumulation including lactate and succinate
  • Identified dysregulated RNAs and multi-omic integration pathways relevant for clinical translation

Abstract

Acute ischemic stroke (AIS) is a time-critical emergency in which rapid diagnosis within established therapeutic windows is essential to optimize outcomes. Fluid biomarkers offer a promising adjunct to clinical and neuroimaging assessment but their temporal dynamics in the acute phases remain incompletely characterized. We performed a hybrid umbrella review of systematic reviews and meta-analyses evaluating fluid biomarkers in AIS versus controls or stroke mimics. Quantitative synthesis of primary studies (random effects meta-analysis of standardized mean differences) was stratified by clinically relevant time windows. Heterogeneity, small-study effects, and excess significance bias were assessed. We included 27 publications (18 biochemistry, 1 metabolomic, 10 transcriptomic, 5 cell-free-DNA cfDNA). Across all time points, the largest effect sizes were observed for neuron-specific enolase (NSE), ischemia-modified albumin (IMA), d -dimer, S100B, GFAP, and IL-6. Looking at metabolites, studies revealed early accumulation of lactate, succinate, glutamate and lysophosphatidylcholines, alongside depletion of arginine, citrulline, and citrate. A catalog of 220 micro-RNAs (132 upregulated; 108 downregulated) identified robust markers (miR-16-5p, let-7e-5p, miR-107, miR-451a, and miR-126-3p). 46 circulating RNAs and 55 long-non-coding RNAs were consistently dysregulated. Five studies reported elevated nuclear and mitochondrial cfDNA within 6 h. Fluid biomarkers exhibit a temporally evolving signature: early coagulopathy ( d -dimer), glial activation (GFAP, S100B), and inflammation (IL-6), followed by neuronal necrosis (NSE) and oxidative stress (IMA) within 24 h. Multi-omic integration, including metabolomics, transcriptomics and cfDNA, highlights convergent pathways (PI3K/Akt, NF-κB, immunometabolism) and supports the development of rapid, point-of-care panels. Standardized sampling windows and harmonized assay protocols are essential for clinical translation and prospective validation in prehospital settings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bombaci et al. (2026) studied this question.

synapsesocial.com/papers/6997b911baf9c852d8c25fc6https://doi.org/10.1007/s00415-026-13702-7
Ask AI
Helpful
Bookmark
Share
View Full Paper